The Discounted Cash Flow (DCF) valuation of Regenxbio Inc (RGNX) is (113.59) USD. With the latest stock price at 11.16 USD, the upside of Regenxbio Inc based on DCF is -1117.9%.
Based on the latest price of 11.16 USD and our DCF valuation, Regenxbio Inc (RGNX) is a sell. selling RGNX stocks now will result in a potential gain of 1117.9%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.6% - 8.1% | 6.8% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (520.46) - (65.43) | (113.59) |
| Upside | -4763.6% - -686.3% | -1117.9% |